Floatz logo

Clozapine

Dual Diagnosis

Dartmouth-Hitchcock Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Dual Diagnosis cohort.

Asset / SponsorPhaseRating
Risperdal
Lone Baandrup
Phase 4BBB
Zofran
University of Texas Southwestern Medical Center
Phase 4BB
DESIPRAMINE
Dartmouth-Hitchcock Medical Center
Phase 2B
Marijuana
Dartmouth-Hitchcock Medical Center
Phase 1CCC
NEPENTHE
St Patrick's Hospital, Ireland
N/AD
DEXKETOPROFEN
St Patrick's Hospital, Ireland
N/AD
METAMIZOLE
St Patrick's Hospital, Ireland
N/AD

Same molecule, other indications

Clozapine is also rated in:

Psychotic DisorderDormant
BBB
Indicative ·
78 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →